1-12 of 12
oncolytic virotherapy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Oncolytic Virus Therapy with HSV-1 for Hematologic Malignancies

Ryo Ishino, Yumi Kawase, MD, Toshio Kitawaki, MD PhD, Naoshi Sugimoto, MD PhD, Maki Oku, MD, Shumpei Uchida, MD, Osamu Imataki, MD PhD, Akihito Matsuoka, MD PhD, Teruhisa Taoka, MD PhD, Kimihiro Kawakami, MD PhD, Tomoki Todo, MD PhD, Akifumi Takaori-Kondo, MD PhD, Norimitsu Kadowaki, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3242.
https://doi.org/10.1182/blood-2019-127754
Published: 2019
Journal Articles

T Cell Responses to Tumor Associated Antigens in Multiple Myeloma Patients Treated with MV-NIS, an Oncolytic Measles Virus

Nandakumar Packiriswamy, PhD DVM, Deepak Upreti, PhD, Yumei Zhou, PhD, Angela Dispenzieri, MD, Kah-Whye Peng, PhD, Stephen J. Russell, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3793.
https://doi.org/10.1182/blood.V130.Suppl_1.3793.3793
Published: 2017
Journal Articles

Oncolytic Virotherapy in Multiple Myeloma: A Possible Alternative Role of Bovine Viruses.

Valentina Marchica, Gaetano Donofrio, PhD, Rosanna Vescovini, PhD, Giulia Tebaldi, Alfonso Rosamilia, Daniela Guasco, Paola Storti, PhD, Marina Bolzoni, PhD, Federica Costa, Chiara Schifano, MSc, Sabrina Bonomini, MSc, Fabrizio Accardi, MD, Francesco Piazza, MD, Franco Aversa, MD, Nicola Giuliani, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2093.
https://doi.org/10.1182/blood.V128.22.2093.2093
Published: 2016
Journal Articles

Feasibility of a Cell-Based Oncolytic Virotherapy Targeting Bone Marrow Lesions of Multiple Myeloma

Kota Sato, MD, Muneyoshi Futami, MD PhD, Ung Weng Chit, Takafumi Nakamura, MD PhD, Arinobu Tojo, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4499.
https://doi.org/10.1182/blood.V128.22.4499.4499
Published: 2016
Journal Articles

Exploring the Possibility of Using Herpes Simplex Virus in Oncolytic Virotherapy of Multiple Myeloma

Jayeeta Ghose, Luke Russell, Enrico Caserta, Ramasamy Santhanam, Alena Cristina Jaime-Ramirez, Domenico Viola, Amrita Krishnan, Craig C Hofmeister, Balveen Kaur, Flavia Pichiorri, PhD
Journal: Blood
Blood (2016) 128 (22): 4467.
https://doi.org/10.1182/blood.V128.22.4467.4467
Published: 2016
Journal Articles

Modulation of Natural Killer Cell Activity in the Setting of Oncolytic Virotherapy and with a Chimeric Antigen Receptor

Chen Xilin, Jianfeng Han, Chu Jianhong, Walter Meisen, Zhang Jianying, E. Antonio Chiocca, Balveen Kaur, Michael A. Caligiuri, MD, Jianhua Yu, PhD
Journal: Blood
Blood (2015) 126 (23): 210.
https://doi.org/10.1182/blood.V126.23.210.210
Published: 2015
Journal Articles

Synergistic Antitumor Effects of Chimeric Antigen Receptor-Modified T Cells and Oncolytic Virotherapy

Xingbing Wang, PhD MD, Stephen Gottschalk, MD, Xiao-Tong Song, PhD
Journal: Blood
Blood (2014) 124 (21): 5808.
https://doi.org/10.1182/blood.V124.21.5808.5808
Published: 2014
Journal Articles

Combination Immunotherapy of Advanced Lymphoma with Oncolytic Vaccinia Virus and Checkpoint Inhibitor Following Local Tumor Irradiation

Boris Minev, MD, Holbrook Kohrt, MD, Mehmet Kilinc, PhD, Nanhai Chen, PhD, Audrey Feng, Maysam Pessian, Ulrike Geissinger, Erik Haefner, Desislava Tsoneva, Kliment Bozhilov, Idit Sagiv Barfi, PhD, Xing Zhao, Narendiran Rajasekaran, PhDMSc, Ronald Levy, MD, Aladar Szalay, PhD
Journal: Blood
Blood (2014) 124 (21): 4487.
https://doi.org/10.1182/blood.V124.21.4487.4487
Published: 2014
Journal Articles

Oncolytic virotherapy for ALL: MSCs to the rescue

Edwin M. Horwitz
Journal: Blood
Blood (2014) 123 (9): 1286–1287.
https://doi.org/10.1182/blood-2014-01-546747
Published: 2014
Journal Articles

In Vitro Stromal Co-Culture Model For The Evaluation Of Reovirus Oncolytic Therapy For Refractory Pediatric Leukemia

Gaya Narendran, Matthew F. Clarkson, Randal Johnston, PhD
Journal: Blood
Blood (2013) 122 (21): 5407.
https://doi.org/10.1182/blood.V122.21.5407.5407
Published: 2013
Journal Articles

Early Results of a Clinical Trial Using Targeted Oncolytic Virotherapy in Kaposi Sarcoma Herpes Virus (KSHV) Associated Multicentric Castleman’s Disease (MCD).

Deirdre O’Mahony, MD, Wendy Bernstein, MD, Kathy Wyvill, RN, Karen Aleman, RN, Denise Whitby, PhD, Seth Steinberg, PhD, Giovanna Tosato, MD, Stefania Pittaluga, MD, Elaine S. Jaffe, MD, Robert Yarchoan, MD, Richard F. Little, MD
Journal: Blood
Blood (2007) 110 (11): 514.
https://doi.org/10.1182/blood.V110.11.514.514
Published: 2007
Journal Articles

Oncolytic Virotherapy for Multiple Myeloma.

Judith Andrea McCart, MD, Hui Deng, Nan Tang, MSc, Gillian Sleep, Navneet Mehta, MSc, Amaalia Stief, Xiu-Zhi Yang, Kimberly Cottick, Colin McKerlie, Suzanne Trudel, MD, Keith Stewart, MD
Journal: Blood
Blood (2006) 108 (11): 3486.
https://doi.org/10.1182/blood.V108.11.3486.3486
Published: 2006